Technology Development for New Affinity Reagents Against the Human Proteome (U54)

The summary for the Technology Development for New Affinity Reagents Against the Human Proteome (U54) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Technology Development for New Affinity Reagents Against the Human Proteome (U54)
	CFDA Number:	93.310
	CFDA Description:	Trans-NIH Research Support
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-RM-10-018
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 03, 2010
	Creation Date:	Dec 03, 2010
	Original Closing Date for Applications:	Feb 04, 2011
	Current Closing Date for Applications:	Feb 04, 2011
	Archive Date:	Mar 07, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$5,000,000
	Federal Grant Award Ceiling:	$1,000,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: The NIH Common Fund Protein Capture Program aims to develop over time the capacity to generate a community resource of high quality renewable affinity reagents for all human proteins (see http://nihroadmap.nih.gov/proteincapture). This Funding Opportunity Announcement (FOA) is a component of the Protein Capture Program, and is designed to solicit grant applications that would develop and/or improve approaches for obtaining protein affinity reagents at high throughput and low cost. Applications should describe an approach for improving and/or developing protein affinity reagent technologies that can be ready for proteome scale projects within three to five years.However, it is expected that the technologies proposed have already shown solid proof of principle, yet need additional funds to demonstrate scalability. It should also be noted that the main goal of this solicitation is to improve the overall production pipeline from targets selection to the validation of the protein affinity reagents; thus applications should discuss their development efforts within a production pipeline context. However, the proposed improvements or developments could be across the entire process or have a main focus on specific aspects of the process.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-rm-10-018.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • NIH-HMO Collaboratory Coordinating Center Limited Competition (U54); • Production of Affinity Reagents for Human Transcription Factors (U54); • Mechanisms of Adverse Drug Reactions in Children (R01); • Institutional Clinical and Translational Science Award (U54); • Integrating Comparative Effectiveness Research Findings into Care Delivery through Economic Incentiv...; • Using Metabolomics to Investigate Biological Pathways and Networks (R01); • Assay Development for High Throughput Molecular Screening (R21); • Membrane Protein Production and Structure Determination (R01); • Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Cent...; • 2007 NIH Director's Pioneer Award Program (DP1)